الوصف
Mounjaro contains tirzepatide 12.5 mg/0.5 ml, a dual GIP and GLP-1 receptor agonist given once weekly by subcutaneous injection.
استخدامات
- يتحكم في سكر الدم لدى مرضى السكري من النوع الثاني
- Produces significant weight reduction alongside diet and activity
كيفية الاستخدام
Inject subcutaneously into the abdomen, thigh or upper arm once weekly on the same day, rotating the injection site. Store in the refrigerator as directed.
هام
Nausea, reduced appetite and constipation are common, especially when the dose increases. Not for type 1 diabetes. Contraindicated with a personal or family history of medullary thyroid carcinoma. Prescription medicine – use only under a doctor’s direction.
المراجعات
لا توجد مراجعات بعد.